Encompass Health Corp (EHC)

Encompass Health Corporation is a NYSE-listed common stock company in the healthcare sector. Through its inpatient rehabilitation hospitals in the United States and Puerto Rico, the company provides specialized rehabilitative treatment for patients recovering from major injury or illness and working to restore functional ability and independence. Its services include medical, nursing, therapy, and other ancillary care for conditions such as stroke, neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic cases, and amputations. The company serves patients through Medicare, managed care plans, private insurers, state governments, and other payors. Formerly known as HealthSouth Corporation, it adopted the Encompass Health name in January 2018. Incorporated in 1984, the company is headquartered in Birmingham, Alabama.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-EHC
$121.37
-2.2% Downside
Fair
$148.17
19.4% Upside
Undervalued
Great
0.7%
20.3x
4.7x
2.0x
12.242 B
15.84 B
17.8%
99.0%
4.0
12.1%
68.5%
Valuation • Fair Value

Encompass Health Corp (NYSE-EHC) Fair Value by Valuation Model

Review the available estimates for Encompass Health Corp (NYSE-EHC), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$121.37

Estimated downside of 2.2% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$110.45

Discounted cash flow valuation reference.

Ben Graham Formula Value

$67.90

Classic Ben Graham valuation formula reference.

DDM Fair Value

$165.55

Dividend discount model valuation reference.

Comps Fair Value

$117.55

Comparable-company valuation reference.

Analyst Price Target

$148.17

Analysts imply upside of 19.4%.

How to read these valuation models

Use the 7 available valuation references for Encompass Health Corp (NYSE-EHC) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Encompass Health Corp (NYSE-EHC)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

6.206 B

Current operating scale indicator.

Revenue Forecast

6.46 B

Forward revenue estimate.

EBITDA

1.464 B

Current operating profitability reference.

EBITDA Forecast

1.384 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Encompass Health Corp (NYSE-EHC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Encompass Health Corp (NYSE-EHC)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-2.78

No elevated caution signal from this screen.

Altman Z-Score

4.0

Relatively strong balance-sheet zone.

FCF / Net Income

68.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Encompass Health Corp (NYSE-EHC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Encompass Health Corp (NYSE-EHC)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.7%

Current income yield reference.

Payout Ratio

12.1%

Dividend payout reference.

How to read events and dividends

Review the currently available dividend data for Encompass Health Corp (NYSE-EHC). No upcoming company event date is included in the latest data.

Stock Forecast • Technical Outlook

Encompass Health Corp (NYSE-EHC) Stock Forecast & Technical Outlook

Review Encompass Health Corp (NYSE-EHC) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Encompass Health Corp (NYSE-EHC) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Encompass Health Corp (NYSE-EHC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Encompass Health Corp (NYSE-EHC) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Encompass Health Corp (NYSE-EHC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Encompass Health Corp (NYSE-EHC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Encompass Health Corp (NYSE-EHC)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Encompass Health Corp (NYSE-EHC) has a Strong Buy consensus, with 12 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 12
Hold 0
Sell 0
FAQ • Fast Investor Answers

Encompass Health Corp (NYSE-EHC) Stock FAQ

Data-supported answers about Encompass Health Corp (NYSE-EHC), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$121.37
Estimated downside 2.2%
Valuation Rating
Overvalued
Estimated downside of 2.2%
Analyst Target
$148.17
Implied upside 19.4%
Financial Health
Great
Current financial-health read

The current fair value estimate for Encompass Health Corp (NYSE-EHC) is $121.37. This implies an estimated downside of 2.2% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 2.2% versus the current market price.

The available analyst price target for Encompass Health Corp (NYSE-EHC) is $148.17. The analyst target implies estimated upside of 19.4%.

The current financial health read for Encompass Health Corp (NYSE-EHC) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 0.7%.

The current P/E ratio listed for Encompass Health Corp (NYSE-EHC) is 20.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Encompass Health Corp is 12.242 B.

The current enterprise value listed for Encompass Health Corp is 15.84 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Encompass Health Corp is NYSE-EHC, and the stock is listed on NYSE.

Encompass Health Corp (NYSE-EHC) is listed on NYSE.

The current debt-to-total-capital ratio listed for Encompass Health Corp is 17.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Encompass Health Corp is 99.0%. Free float helps investors understand how much of the share base is available for public trading.